BCAL Diagnostics appoints Shane Ryan as new CEO
SYDNEY, AUSTRALIA: BCAL Diagnostics Limited (ASX:BDX) has announced the appointment of Shane Ryan as the new CEO, effective from April 2, 2024. Ryan, previously the...
BCAL Diagnostics appoints Dr John Hurrell as CEO
SYDNEY, AUSTRALIA: BCAL Diagnostics Limited announced the appointment of experienced life science and healthcare executive Dr John Hurrell as its Chief Executive Officer (CEO). Dr...
BCAL Diagnostics lists on ASX after raising $10 million in IPO
SYDNEY, AUSTRALIA: BCAL Diagnostics listed on the Australian Securities Exchange (ASX) following an Initial Public Offering (IPO) that raised $10 million from investors. The offer...